N - CARDIOMETABOLIC

Guide patient selection for pharmacotherapy by other factors commonly seen in SCI, such as low levels of HDL-C. Initiate statin monotherapy using at least a moderate-intensity statin (e.g., rosuvastatin 10–20 mg/day). Refer to the Canadian Heart and Stroke Guideline when initiating statins. (Adapted from NASH 2018, p.411; Level C)